Filter
722
Text search:
quality
assured
medical
products
Featured
Recommendations
86
New Publications
238
Language
Document type
No document type
384
Guidelines
120
Studies & Reports
112
Manuals
48
Strategic & Response Plan
43
Training Material
10
Situation Updates
2
Fact sheets
2
Resource Platforms
1
Countries / Regions
India
38
Global
30
Kenya
23
Nigeria
19
Western and Central Europe
19
Uganda
17
Ethiopia
13
Zambia
13
Ghana
12
Tanzania
11
Myanmar / Burma
11
Nepal
10
Liberia
9
Philippines
9
South–East Asia Region
9
Bangladesh
8
Eastern Europe
8
Malawi
7
Lesotho
7
Africa
7
Sierra Leone
6
Cambodia
6
South Africa
6
Latin America and the Carribbean
6
Ukraine
5
West and Central Africa
5
Asia
5
Burkina Faso
4
Zimbabwe
4
Rwanda
4
Namibia
4
East and Southern Africa
4
Senegal
3
Congo, Democratic Republic of
3
Pakistan
3
Middle East and North Africa
3
Guinea
2
South Sudan
2
Iraq
2
Afghanistan
2
Germany
2
Indonesia
2
Mozambique
2
Sudan
2
Eswatini/ Swaziland
2
Sri Lanka
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Laos
2
Georgia
2
USA
1
Saudi Arabia
1
Cameroon
1
Haiti
1
Jordan
1
Syria
1
Thailand
1
Benin
1
Central African Republic
1
Brazil
1
Switzerland
1
Botswana
1
Libya
1
Guatemala
1
Bhutan
1
Tajikistan
1
Estonia
1
Iran
1
North America
1
Gabon
1
Maldives
1
United Kingdom
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
252
Clinical Guidelines
93
Public Health
47
Pharmacy & Technologies
35
Women & Child Health
29
Key Resources
23
Capacity Building
11
Toolboxes
TB
87
AMR
78
HIV
64
Pharmacy
51
COVID-19
36
NTDs
25
Rapid Response
21
Mental Health
17
Caregiver
12
Ebola
10
Polio
10
Conflict
10
Refugee
10
Global Health Education
10
Disability
9
NCDs
9
Natural Hazards
6
Planetary Health
6
Zika
5
Health Financing Toolbox
3
Specific Hazards
2
Cholera
1
Social Ethics
1
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i
...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi
...
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicable and Noncommunicable Diseases, welcomed participan
...
This background document (EUR/RC72/BG/7) was considered and adopted by the WHO Regional Committee for Europe at its 72nd session (Tel Aviv, Israel, 12–14 September 2022), together with the working document (EUR/RC72/7) and information document (EUR/RC72/INF./4). The Regiona
...
Regional implementation framework for elimination of cervical cancer as a public health problem: 2021–2030
recommended
Cervical cancer continues to be a significant public health problem and a major cause of premature mortality among women, disproportionately affecting the socioeconomically disadvantaged population in low- and middle-income countries (LMICs). In the absence of implementing the known evidence-based,
...
The desired impact of the OH JPA is a world better able to prevent, predict, detect and
respond to health threats and improve the health of humans, animals, plants and the
environment while contributing to sustainable development. The OH JPA aims to work
towards this vision in the following way:
...
Rabies has an enormous impact on both agriculture and conservation biology, but its greatest burden is undeniably on public health. As such, routine methods for rapid risk assessment after human exposures to rabies as well as applications for laboratory-based surveillance, production of biologicals
...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys
...
This document aims to assist countries to take the first step towards better considering gender and equity issues in their efforts to tackle antimicrobial resistance (AMR), to inform the implementation of strategies in national action plans and contribute to improved reach and effectiveness of AMR e
...
The WHO standard: Universal access to rapid tuberculosis diagnostics sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics (WRDs), increase bacteriologically confirmed tuberculosis and drug resistance detection, and reduce the time to diagnosis. WHO-recommended rapid diagn
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
